- Home
- / Genomic Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Genomic Health financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$394.1 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 206.1M | 235.2M | 261.6M | 275.7M | 287.5M | 327.9M | 340.8M | 394.1M |
| Revenue growth, % | 5.4% | 4.3% | 14.1% | |||||
| Cost of goods sold | 33.8M | 37.0M | 42.1M | 48.7M | 53.8M | 57.3M | 54.7M | |
| Gross profit | 172.3M | 198.2M | 219.5M | 227.0M | 233.7M | 270.6M | 286.0M | |
| Gross profit margin, % | 83.6% | 84.3% | 83.9% | 82.3% | 81.3% | 82.5% | 83.9% | |
| General and administrative expense | 40.5M | 47.1M | 54.4M | 59.7M | 64.3M | 73.3M | 72.7M | 76.9M |
| Operating expense total | 164.0M | 189.7M | 231.3M | 250.6M | 267.7M | 286.0M | 292.5M | 305.9M |
| EBIT | 8.3M | 8.4M | (11.8M) | (23.6M) | (34.0M) | (15.4M) | (6.4M) | 23.9M |
| EBIT margin, % | 4.0% | 3.6% | -4.5% | -8.6% | -11.8% | -4.7% | -1.9% | 6.1% |
| Investment income | 221.0K | 295.0K | 222.0K | 192.0K | 221.0K | 418.0K | ||
| Interest income | 934.0K | 2.4M | ||||||
| Pre tax profit | 8.3M | 8.7M | (12.4M) | (24.2M) | (34.3M) | (12.5M) | (2.4M) | 26.9M |
| Income tax expense | 429.0K | 422.0K | 346.0K | 393.0K | (996.0K) | 1.4M | 1.5M | 1.2M |
| Net Income | 7.8M | 8.2M | (12.8M) | (24.6M) | (33.3M) | (13.9M) | (3.9M) | 25.7M |